Ifp Advisors, Inc Sage Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$27.52 - $37.99 $2,256 - $3,115	82 New	82 $13,000
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $2,256 - $3,115	-82 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$30.71 - $45.71 $2,518 - $3,748	82 New	82 $2,000
Q3 2021 Oct 06, 2021	SELL	$40.26 - $57.37 $7,327 - $10,441	-182 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$54.88 - $79.29 $603 - $872	11 Added 6.43%	182 $10,000

Q1 2021 Apr 30, 2021	SELL	$70.65 - $96.76 $353 - $483	-5 Reduced 2.84%	171 $12,000
Q4 2020 Jan 25, 2021	BUY	$58.41 - $89.06 $10,104 - $15,407	173 Added 5766.67%	176 $16,000
Q3 2020 Oct 29, 2020	BUY	$41.13 - $62.45 $123 - $187	3 New	3 $0
Q2 2020 Aug 05, 2020	SELL	$25.95 - $43.15 $596 - $992	-23 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$26.15 - $77.24 $16,657 - $49,201	-637 Reduced 96.52%	23 $1,000
Q4 2019 Jan 17, 2020	SELL	$60.18 - $154.77 $481 - $1,238	-8 Reduced 1.2%	660 $48,000
Q3 2019 Nov 07, 2019	BUY	$140.29 - $189.96 $92,170 - $124,803	657 Added 5972.73%	668 $97,000
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $46,719 - $85,588	-523 Reduced 97.94%	11 $2,000
Q4 2018 Jan 23, 2019	SELL	$81.94 - $139.71 $163 - $279	-2 Reduced 0.37%	534 $51,000
Q3 2018 Oct 25, 2018	SELL	$138.11 - $169.04 $966 - $1,183	-7 Reduced 1.29%	536 $0
Q2 2018 Aug 07, 2018	BUY	$140.36 - $175.76 $75,513 - $94,558	538 Added 10760.0%	543 $0
Q4 2016 Jun 03, 2019	SELL	N/A	-6 Reduced 54.55%	5 $0
Q1 2016 Jun 03, 2019	BUY	N/A	11	11 $2,000

220

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $730M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.